John Markels

John Markels

Director/Board Member at SANGAMO THERAPEUTICS, INC.

Net worth: 5 205 $ as of 30/06/2026

60 year
Health Technology
Consumer Services

Profile

John H.
Markels
is an Independent Director at Sangamo Therapeutics, Inc. since 2020.
He is a Director at Arcturus Therapeutics, Inc. and Arcturus Therapeutics Ltd. He has been an Independent Director at Arcturus Therapeutics Holdings, Inc. since 2022.
He is an Independent Director at Vaxcyte, Inc. starting in 2026.
Formerly, Dr. Markels was President-Global Vaccines at Merck & Co., Inc. from 2019 to 2022.
Education includes a doctorate from the University of California, Berkeley and an undergraduate degree from the University of Delaware.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
12/06/2025 96,384 ( 0.02% ) 5 205 $ 30/06/2026
05/06/2026 0 ( -.--% ) - $ 30/06/2026

John Markels active positions

CompaniesPositionStart
SANGAMO THERAPEUTICS, INC. Director/Board Member 11/02/2020
ARCTURUS THERAPEUTICS HOLDINGS INC. Director/Board Member 08/12/2022
VAXCYTE, INC. Director/Board Member 16/07/2026
Director/Board Member -
Director/Board Member -

Former positions of John Markels

CompaniesPositionEnd
MERCK & CO., INC. Corporate Officer/Principal 01/03/2022
See the detail of John Markels's experience

Training of John Markels

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

16

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology